Sulfamethoxazole/Trimethoprim Recalled
June 06, 2025
On June 2, 2025, Amneal Pharmaceuticals recalled three lots of sulfamethoxazole/trimethoprim tablets, USP, 400mg/80mg to the consumer level.
Important Notices
Metoclopramide Recall
June 02, 2025
On May 23, 2025, Teva Pharmaceuticals USA recalled one lot of metoclopramide 10mg tablets to the consumer level.
Gamunex-C 40G Vials Withdrawn
April 08, 2025
On March 21, 2025, Grifols Therapeutics LLC withdrew one additional lot of Gamunex-C® (immune globulin injection [human]
Sodium Bicarbonate Recalled
March 26, 2025
On March 13, 2025, Exela Pharma Sciences, LLC recalled two lots of 8.4% sodium bicarbonate injection, USP 50mEq/50mL.
Gamunex-C Lot Withdrawn
March 05, 2025
On Feb. 20, 2025, Grifols Therapeutics LLC withdrew one lot Gamunex-C® (immune globulin injection [human], 10% caprylate/chromatography purified) 40G vial to the consumer level for due to an increased rate of reported hypersensitivity reactions with the affected lot.
Fentanyl Transdermal Recalled
February 21, 2025
On Jan. 31, 2025, Alvogen, Inc. issued a recall for one lot to the consumer level for Fentanyl Transdermal System 25 mcg/h transdermal patches.
Orders may arrive late due to Winter Weather
February 18, 2025
Orders may arrive late due to Winter Weather. We are working with our carriers, so you receive your medication as soon as possible. Please check your tracking information for the latest updates. Express Scripts sends our best wishes for your safety during this time. Thank you!
Additional Lot of Xembify Withdrawn
February 11, 2025
On Jan. 10, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial due to an increased rate of reported hypersensitivity reactions with the affected lot.
Epinephrine Nasal Solution - FDA Warning
January 22, 2025
On Jan. 16, 2025, the FDA warned healthcare professionals not to use unapproved epinephrine nasal solutions from BPI Labs and Endo
One Lot of Xembify Withdrawn
January 17, 2025
On Jan. 13, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial